Statement Of Cash Flows [Abstract]
| Concept |
2021-01-01 to 2021-12-31 |
2020-01-01 to 2020-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Cash flows from (used in) operations before changes in working capital |
19,685
iso4217:HRK
|
33,700
iso4217:HRK
|
| Adjustments for decrease (increase) in loans and advances | — | — |
| Adjustments for decrease (increase) in loans and advances to customers |
1,923
iso4217:HRK
|
2,961
iso4217:HRK
|
| Adjustments for decrease (increase) in biological assets |
3,116
iso4217:HRK
|
3,288
iso4217:HRK
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories |
5,235
iso4217:HRK
|
754,000
iso4217:HRK
|
| Income taxes paid, classified as operating activities |
0
iso4217:HRK
|
0
iso4217:HRK
|
| Cash flows from (used in) financing activities [abstract] | ||
| Repayments of bonds, notes and debentures |
3,463
iso4217:HRK
|
4,040
iso4217:HRK
|